Lung Cancer Screening Pushes 20-Year Survival Rate to 80%
Results of a large, international study show the benefit of annual, low-dose CT scans for those diagnosed early persists at 20 years.
Stay updated with breaking news from Cardiac Action Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results of a large, international study show the benefit of annual, low-dose CT scans for those diagnosed early persists at 20 years.
Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves the survival rate of cancer patients over a 20-year period, according to a large-scale international study being presented by Mount Sinai researchers at the annual meeting of the Radiological Society of North America.
Over a 20-year period, the survival rate of cancer patients is significantly increased when early-stage lung cancer is detected by low-dose computed tomography (CT) screening.
/PRNewswire/ -- Diagnosing early-stage lung cancer with low-dose CT screening drastically improves the long-term survival rate of cancer patients, according to...
Regular screening significantly increases survival in lung cancer patients, as it allows early cases to be diagnosed and treated.